ECG Morphology Analysis Using PCA for TdP Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for analyzing ECG data in pharmaceutical testing are limited by the reliance on Q-T interval measurements, which are complicated by heart rate hysteresis and fail to identify new morphological features that could predict drug-induced Torsade-de-Pointes (TdP) effectively, due to the complexity and magnitude of the data involved.

Innovation Solution

The method employs new T wave morphological features, principal component analysis (PCA), and a database to generate a model ECG signal for improved analysis, allowing for the identification of correlations and confidence intervals in ECG data, enabling more accurate measurement of Q-T intervals and detection of potential TdP indicators.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If Q-T interval measurement is used to predict drug-induced TdP, then regulatory approval can be obtained, but measurement accuracy is reduced due to heart rate hysteresis effects

Engineering Contradiction:
Improvepredictive capabilityVSAvoidQ-T interval measurement accuracy
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The system performs preliminary identification of R-R interval changes and pre-determines when Q-T interval measurements should be collected, accounting for heart rate hysteresis effects. By anticipating the optimal measurement timing before actual TdP events occur, the system improves both measurement accuracy and predictive reliability

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system creates a reference model of normal ECG morphology through principal component analysis. This reference copy is then compared against actual patient data to identify deviations that may indicate TdP, improving measurement precision by providing a standardized baseline for comparison

Inventive Principle:
Principle #26Copying

2Reliability

If comprehensive ECG morphological analysis is performed to identify new predictive features, then predictive capability improves, but data complexity and analysis difficulty increase

Engineering Contradiction:
ImproveTdP prediction accuracyVSAvoiddata analysis complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system extracts only the most significant morphological features from comprehensive ECG data using statistical analysis and principal component analysis. By isolating and focusing on key predictive features rather than analyzing all raw data, the system improves TdP prediction accuracy while reducing data analysis complexity

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system transforms raw ECG signal data into standardized morphological parameters and principal components. This parameter transformation simplifies the data structure while preserving predictive information, making complex ECG analysis more manageable and interpretable

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If sophisticated timing methods are implemented to account for hysteresis effects, then Q-T interval measurement accuracy improves, but device complexity increases

Engineering Contradiction:
ImproveQ-T interval measurement accuracyVSAvoidmeasurement system complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system replaces complex mechanical timing adjustments with automated computational algorithms that calculate optimal measurement windows based on R-R interval patterns. This substitution of computational methods for mechanical timing mechanisms improves measurement accuracy while keeping the overall system complexity manageable through software-based solutions

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS7769434B2Method of physiological data analysis and measurement quality check using principal component analysis
Publication Date: 2010.08.03 GE PRECISION HEALTHCARE LLC
  • US7769434B2 patent drawing
  • US7769434B2 patent drawing
  • US7769434B2 patent drawing

AI summary

In a method of analyzing patient physiological data, the data is subjected to principal component analysis and compared to a model physiological data principal component analysis. The comparison is used to identify correlations present in the morphology of the patient physiological data. The present invention further includes determining a confidence interval for the detection of a morphological feature and utilizing this confidence interval for improving the quality of the detection of morphological features of the patient physiological data, including automated morphological feature identification.